(Q37843722)

English

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma

scientific article published on 16 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

neuroendocrinology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

Kuniaki Shirao

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Natsuko Tsuda Okita

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ken Kato

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Daisuke Takahari

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yoshinori Hirashima

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Takako E Nakajima

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Junichi Matsubara

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Tetsuya Hamaguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yasuhide Yamada

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yasuhiro Shimada

9

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hirokazu Taniguchi

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

16 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

161-165

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

https://scigraph.springernature.com/pub.10.1007/s10120-011-0025-5

0 references

Carcinoid TumorsAn analysis of 2837 cases

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Small-cell carcinomas of the gastrointestinal tract: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0025-5

21 January 2018

Gastric small-cell carcinoma in Japan: a case report and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type

1 reference

https://pubmed.ncbi.nlm.nih.gov/21327441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-011-0025-5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37843722&oldid=2132373646"